Position in GHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$205,277,533
+$97,343,174 QoQ
Shares Held
7,636,813
-0.5% QoQ
Ownership
11.1%
of shares outstanding
% of Portfolio
1.81%
of 13F equity value
Holder Rank
#3
of 62 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. GHRS ranks #13 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,883,524 | $330,779,298 |
All Filings in GHRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-08-12 | $148,090,783 | 4,897,182 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $205,277,533 | 7,636,813 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $107,934,359 | 7,676,697 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $97,494,051 | 7,676,697 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $109,776,767 | 7,676,697 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $93,578,936 | 7,676,697 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $76,599,467 | 6,944,648 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $46,806,823 | 6,686,689 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $44,733,949 | 6,686,689 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $76,975,693 | 6,601,689 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $66,643,271 | 6,251,714 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $32,406,531 | 5,587,333 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $56,152,696 | 5,587,333 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $66,293,706 | 5,587,333 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $44,593,476 | 5,581,161 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $47,612,185 | 4,898,373 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $56,919,094 | 4,898,373 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $48,885,762 | 4,898,373 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $88,291,865 | 4,827,330 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $66,344,850 | 2,843,757 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $66,487,891 | 3,013,957 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $64,732,692 | 2,978,955 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||